Contemporary outcomes of initial treatment strategy of endovascular intervention or bypass in patients with critical limb ischemia

Abstract

Objective

The optimal management for revascularization after critical limb ischemia (CLI) is controversial due to limited studies comparing long-term results of endovascular and open techniques. This study compares long-term outcomes after initial management of CLI via lower extremity bypass (LEB) and percutaneous vascular intervention (PVI).

Methods

This retrospective cohort study investigates outcomes of patients who underwent endovascular or open surgical management for CLI at a single institution from 2013–2018. All patients with diagnosis of CLI were included and separated based on initial therapy of PVI or LEB. Demographic, procedural, and follow-up data were assessed. Primary endpoints included major adverse limb events (MALE), specifically the need for major amputation and reintervention. Secondary endpoints included mortality at 30 days and one year. A multivariable Cox Proportional Hazard regression model was used to assess the relationship between Surgery group and time to MALE/death while controlling for confounding variables.

Results

This study identified 338 patients with an initial diagnosis of CLI who underwent either LEB (n = 108, 32%) or PVI (n = 230, 68%). The average age was 71.4, 54.4% were male, 30% were African American, 53.6% were diabetic, and 93.2% had hypertension. Patients who underwent LEB were more predominantly smokers (p = .003) and less predominantly on dialysis at time of surgery (p = .01). Re-intervention rates in the bypass group (11%) were not significantly different than the PVI group (9%; p = .95). In the bypass group, 20 (19%) patients had a major amputation with a median time of 189.5 days compared to 23 (10%) patients at a median time of 113 days in the PVI group; however, this difference was not significant (p = .16). There was no significant difference in 1-year mortality between the LEB (2%) and PVI group (4%; p = .2). The cumulative incidence of MALE/death at 30 days was 4.0% in the bypass group and 3.7% in the PVI group (p = .2). Incidences of MALE/death were 21.1% and 48.5% in the bypass group and 19.7 and 45.9% in the PVI group at one and 2 years, respectively. Intervention type was not found to be significantly associated with MALE/death after controlling for possible confounders (HR = 0.82, p = .43).

Conclusions

In the initial management of CLI, there is no significant difference in long-term outcomes in terms of major amputation, need for reintervention, limb-salvage, and 1-year mortality.

Keywords

Critical limb ischemia endovascular interventions bypass surgery

Get full access to this article

View all access options for this article.

References

Fowkes

FGR

Aboyans

Fowkes

FJI

, et al. Peripheral artery disease: epidemiology and global perspectives. Nat Rev Cardiol 2017; 14: 156–170.

Norgren

Hiatt

Dormandy

, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45: S5–S67.

Nehler

Duval

Diao

, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 2014; 60: 686–695.

Agarwal

Sud

Shishehbor

. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients from 2003–2011. J Am Coll Cardiol 2016; 67: 1901–1913.

Lawall

Zemmrich

Bramlage

, et al. Health related quality of life in patients with critical limb ischemia. Vasa 2012; 41: 78–88.

Monaro

West

Gullick

. An integrative review of health-related quality of life in patients with critical limb ischaemia. J Clin Nurs 2017; 26: 2826–2844.

Duff

Mafilios

Bhounsule

, et al. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag 2019; 15: 187–208.

Kolte

Kennedy

Shishehbor

, et al. Thirty-day readmissions after endovascular or surgical therapy for critical limb ischemia: analysis of the 2013 to 2014 nationwide readmissions databases. Circulation 2017; 136: 167–176.

Peacock

Keo

Duval

, et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005–2008. Prev Chronic Dis 2011; 8: A141.

10.

Barshes

Chambers

Cohen

, et al. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg 2012; 56: 1015–1024.

11.

Schanzer

Hevelone

Owens

, et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007; 46: 1180–1190.

12.

Lancaster

Conrad

Patel

, et al. Predictors of early graft failure after infrainguinal bypass surgery: a risk-adjusted analysis from the NSQIP. Eur J Vasc Endovasc Surg 2012; 43: 549–555.

13.

Egorova

Guillerme

Gelijns

, et al. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. J Vasc Surg 2010; 51: 878–885.

14.

Nowygrod

Egorova

Greco

, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 2006; 43: 205–216.

15.

Teraa

Conte

Moll

, et al. Critical limb ischemia: current trends and future directions. J Am Heart Assoc 2016; 5: e002938.

16.

Bradbury

Adam

Bell

, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010; 51(5 Suppl): 5S–17S.

17.

Conte

. Understanding objective performance goals for critical limb ischemia trials. Semin Vasc Surg 2010; 23: 129–137.

18.

Cull

Langan

Gray

, et al. Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg 2010; 210: 555–561.

19.

Gentile

Lundberg

Hultgren

. Outcome for endovascular and open procedures in infrapopliteal lesions for critical limb ischemia: registry based single center study. Eur J Vasc Endovasc Surg 2016; 52: 643–649.

20.

Graor

Douville

Comerota

, et al. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251–266.

21.

Ouriel

Shortell

DeWeese

, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021–1030.

22.

Ouriel

Veith

Sasahara

. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or peripheral arterial surgery (TOPAS) investigators. N Engl J Med 1998; 338: 1105–1111.

23.

Kudo

Chandra

Kwun

, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 2006; 44: 304–313.

24.

Soga

Mii

Aihara

, et al. Comparison of clinical outcome after bypass surgery vs endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. Circ J 2013; 77: 2102–2109.

25.

Ghoneim

Elwan

Eldaly

, et al. Management of critical lower limb ischemia in endovascular era: experience from 511 patients. Int J Angiol 2014; 23: 197–206.

26.

Abu Dabrh

Steffen

Asi

, et al. Bypass surgery versus endovascular interventions in severe or critical limb ischemia. J Vasc Surg 2016; 63: 244–253.

27.

Garg

Kaszubski

Moridzadeh

, et al. Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg 2014; 59: 392–399.

28.

Biancari

Arvela

Korhonen

, et al.

End-stage renal disease and critical limb ischemia: a deadly combination?

Scand J Surg 2012; 101: 138–143.

29.

Orimoto

Ohta

Ishibashi

, et al. The prognosis of patients on hemodialysis with foot lesions. J Vasc Surg 2013; 58: 1291–1299.

30.

Gupta

Ramanan

Lynch

, et al. Development and validation of a risk calculator for prediction of mortality after infrainguinal bypass surgery. J Vasc Surg 2012; 56: 372–379.

31.

Meyer

Lang

Borowski

, et al. Critisch collaborators. In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization. J Vasc Surg 2016; 63: 966–973.

32.

Stavroulakis

Borowski

Torsello

, et al. Critisch collaborators. One-year results of first-line treatment strategies in patients with critical limb ischemia (Critisch Registry). J Endovasc Ther 2018; 25: 320–329.

33.

Gray

Grant

Kalbaugh

, et al. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg 2010; 24: 349–359.

34.

Brosi

Baumgartner

Silvestro

, et al. Below-the-knee angioplasty in patients with end-stage renal disease. J Endovasc Ther 2005; 12: 704–713.

35.

O’Hare

Sidawy

Feinglass

, et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 2004; 39: 709–716.

36.

Menard

Farber

Assmann

, et al. Design and rationale of the best endovascular versus best surgical therapy for patients with critical limb ischemia (BEST-CLI) trial. J Am Heart Assoc 2016; 5: e003219.

37.

Farber

Rosenfield

Menard

. The best-cli trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb ischemia. Tech Vasc Interv Radiol 2014; 17: 221–224.